Article
Implementation of CYP2C19 and CYP2D6 genotyping to guide antidepressant use in a large rural health system.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists - 12 Aug 2024
Petry Natasha J, Van Heukelom Joel, Schultz April J, Jacobsen Kristen, Baye Jordan F, Mills Sarah, Figueroa Debbie M, Massmann Amanda
Abstract excerpt
PURPOSE: We describe the implementation and ongoing maintenance of CYP2C19 and CYP2D6 focused pharmacogenetic (PGx) testing to guide antidepressant and antianxiety medication prescriptions in a large rural, nonprofit health system. SUMMARY: Depression and anxiety are common psychiatric conditions. Sanford Health implemented PGx testing for metabolism of cytochrome P450 (CYP) isozymes 2C19 and 2D6 in 2014 to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
